N/A
N=6
Theta Burst Stimulation for Schizophrenia
Schizophrenia · Schizoaffective Disorder
Bottom Line
View on ClinicalTrials.gov: NCT03288779 ↗Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Nov 2019
Primary outcome: Primary: Brief Assessment of Cognition (BACS) Composite T Score — 37.33 Composite T- Score
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Theta Burst Stimulation (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Duke University
- Primary completion
- Jun 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Brief Assessment of Cognition (BACS) Composite T Score |
37.33 | — |
| SECONDARY Change in Gamma and Theta Oscillations as Measured by EEG |
— | — |
Summary
Purpose and objective Schizophrenia is a chronic debilitating illness with cognitive deficits that cause serious impairment in psychosocial recovery and with few treatments to remediate these deficits. One area that holds great promise for the development of novel, effective therapies is noninvasive brain stimulation. The investigators have used one form of brain stimulation, transcranial magnetic stimulation (TMS), for some time to modulate and enhance cognitive function in the brain, especially working memory (WM) function, which has a central role in most executive processing that occurs in the brain. Theta burst stimulation (TBS) is a paradigm of TMS which has been shown to effectively modulate WM. Moreover, TBS can modulate gamma neural oscillations in the brain and neural activity, both of which have been implicated in the physiology of WM and pathophysiology of the disease process in schizophrenia, making these measures highly valuable for assessing physiological effects of TBS on cognition, quality of life and cortical inhibition. The purpose of this study is to evaluate the effect of TBS on WM in patients with schizophrenia, to develop evidence for potential brain stimulation techniques to treat cognitive deficits in schizophrenia.
Study activities and population group: Study subjects will be inpatient schizophrenic individuals with minimal positive symptoms and predominant cognitive deficits at Duke University Hospital. In an initial session they will be screened and taught a WM task. Following this, one TBS session will follow in which TBS will target dorsolateral prefrontal cortex. They will perform the WM task before, with and after the TBS, with an expected pre-post enhancement of WM performance.
Implications - There is a great need for treatments for cognitive deficits in schizophrenia. The results of this study will serve to generate pilot data for a much larger grant to develop a TBS therapy for remediating such cognitive deficits.
Eligibility Criteria
Inclusion Criteria
- Patients aged 18-65 years of age with schizophrenia or schizoaffective disorder
- No other mental health diagnoses
- Right handed males and females
- May have mild positive symptoms (score of 21. Concurrently receiving electroconvulsive therapy (ECT)
Data sourced from ClinicalTrials.gov (NCT03288779). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.